NEW YORK, March 2 (GenomeWeb News) - Spectral Genomics of Houston, Texas, said yesterday that it has agreed to license certain Affymetrix patents to manufacture and sell spotted DNA arrays for use in the diagnostics market.
The agreement will commence "once the necessary regulatory approvals of Spectral Genomics' products have been obtained," the company said.
The license agreement covers Spectral Genomics' Constitutional Chip, slated to be introduced in 2004, as well as additional anticipated specialty arrays to be used in cancer diagnostics.
The company already sells these chips as research products under a licensing agreement it signed with Affy in October. The new agreement pertains to Spectral Genomics' plans to seek regulatory approval for these products as diagnostics.